Compare Unilever plc (UL) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Unilever plc vs State Street SPDR S&P Biotech ETF — how do they compare? Unilever plc trades at $61.89 (market cap $134.06B), while State Street SPDR S&P Biotech ETF trades at $158.17. The key difference: Unilever plc pays a 3.65% dividend while State Street SPDR S&P Biotech ETF pays none, and State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, Unilever plc nearer its low. Which is the better fit depends on your goals.
| UL | XBI | |
|---|---|---|
Market Cap | $134.06B | — |
Sector | Consumer Staples | Broad Market / Factor |
52-Week High | $74.59 | $164.28 |
52-Week Low | $55.05 | $86.92 |
Enterprise Value | $159.86B | — |
Dividend Yield | 3.65% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Unilever plc
Unilever is a diversified personal product (42% of 2021 sales by value), home care (20%), and packaged food (38%) company. Its brands include Knorr soups and sauces, Hellmann's mayonnaise, Lipton teas, Axe and Dove skin products, and the TRESemme haircare brand. The firm has been acquisitive in recent years
Read more on UL →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
